CORRESP 1 filename1.htm greenhygienics-corresp062613.htm
GREEN HYGIENICS HOLDINGS INC
1937 Pendrell Street, Suite 1004, Vancouver, B.C., Canada

June 26, 2013
 
To: United States Securities and Exchange Commission
  Division of Corporation Finance
   
Re: Green Hygienics Holdings, Inc., Form 8-K Filed June 11, 2013 File No. 000-54338
 
Attention of:                                                                                                                                                          
Steve Lo, Staff Accountant

The following are our responses to your comments in your letter dated June 13, 2013:

Form 8-K Filed June 11, 2013

1. Our board of directors did not determine that previously-issued interim financial statements should no longer be relied upon – we were advised by our independent accountant that disclosure should be made or action should be taken to prevent future reliance on our January 31, 2013 interim financial statements. We also note that:
- We were first advised that disclosure should be made or action should be taken to prevent future reliance on the previously issued interim review related to the six month January 31, 2013 financial statements on or about June 7, 2013;
- The financial statements that should no longer be relied upon are dated January 31, 2013 for the three and six months then ended;
- the information provided by the accountant to us and included in the 8K is that the conversion grant date was during the January 31, 2013 quarter and the fair market value of the Company’s common shares on the grant date is used to value the shares issued for settlement which resulted in a $154,000 loss, representing a large percentage of the net loss during the January period end. The debt was agreed to be settled during the January 31, 2013 quarter in common shares, therefore, the transaction should have been recorded as a stock payable; and
- an authorized officer of the Company discussed with the independent accountant the matters disclosed in the filing pursuant to Item 4.02(b).

2. The debt conversion was agreed to by the creditor(s) during the January quarter and, based on the date of the agreement, a conversion value (loss) occurred which was not properly recorded in that quarter. The amended financial information is disclosed in the Company’s April quarter, and is to be attached as an exhibit to the amended 8K. Also to be filed as an exhibit to the amended 8K is our auditors consent letter. An amended January form 10Q will be filed as soon as possible.

Acknowledgment
We acknowledge that:
- The company is responsible for the adequacy and accuracy of the disclosure in the filing;
- Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and
- The company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely

/s/ Dave Ashby
Dave Ashby                                                                                                                                                                    
President, Green Hygienics Holdings, Inc.
 
 
1

 

Per the Company’s debt settlement agreements consummated during its third quarter ended April 30, 2013, a conversion feature was added and agreed to for a settlement of $50,000 in debt prior to February 1, 2013. The conversion feature resulted in a benefit of $204,000 on recognition of the fair market value of the common shares to be issued on conversion, resulting in a loss on conversion of $154,000, increasing the deficit at January 31, 2013 by $154,000, increasing stock payable by $204,000 at January 31, 2013 and reducing loans payable by $50,000 at January 31, 2013. It became necessary to restate the financial statements for the six months ended January 31, 2013. The results of that restatement are as follows:
 
   
January 31, 2013
         
   
As reported
         
Assets
 
(unaudited)
 
Adjustment
 
As restated
 
Current assets
$
           
  Cash
 
       1,585
 
$
0
 
$
1,585
 
Total current assets
 
1,585
   
0
   
1,585
 
                   
Total Assets
$
       1,585
 
$
0
 
$
1,585
 
                   
Liabilities
                 
Current liabilities
                 
  Accounts payable and accrued liabilities
$
      277,456
 
$
0
 
$
277,456
 
  Management fees payable
 
153,004
   
0
   
153,004
 
  Loans payable
 
213,000
   
(50,000
)
 
163,000
 
                   
Total current liabilities
 
643,460
   
(50,000
)
 
593,460
 
                   
                   
Total Liabilities
 
643,460
   
(50,000
)
 
593,460
 
                   
Stockholders' Deficiency
                 
Common Stock, $0.001 par value
200,000,000 Common Shares Authorized       
56,133 Common Shares Issued (July 31, 2012: 42,133)
 
56
   
0
   
56
 
Additional paid-in capital
 
           1,650,037
   
0
   
1,650,037
 
Stock payable
 
              50,000
   
204,000
   
254,000
 
Deficit accumulated during development stage
 
  (2,341,968
)
 
(154,000
)
 
(2,495,968
)
Total stockholders’ deficit
 
(641,875
)
 
50,000
   
(591,875
)
                   
Total liabilities and stockholders’ deficit
$
           1,585
 
$
0
 
$
1,585
 
                                                                                                  
The accompanying condensed notes are an integral part of these financial statements.
 
 
2

 
 
   
For the three months ended January 31, 2013
   
For the six months ended January 31, 2013
 
   
As reported
   
Adjustment
   
As restated
   
As reported
   
Adjustment
   
As restated
 
REVENUE
 
$
0
   
$
0
   
$
0
   
$
0
   
$
0
   
$
0
 
                                                 
EXPENSES
                                               
Business system development
   
0
     
0
     
0
     
0
     
0
     
0
 
Mineral claim impairment loss
   
0
     
0
     
0
     
0
     
0
     
0
 
Professional fees
   
7,002
     
0
     
7,002
     
15,585
     
0
     
15,585
 
Directors fees
   
0
     
0
     
0
     
16,800
     
0
     
16,800
 
Consulting and administration fees
   
24,500
     
0
     
24,500
     
24,500
     
0
     
24,500
 
Management fees
   
0
     
0
     
0
     
22,500
     
0
     
22,500
 
Filing fees
   
2,876
     
0
     
2,876
     
8,822
     
0
     
8,822
 
Office
   
(277
)
   
 0
     
(277
)
   
7,724
     
0
     
7,724
 
Total Expenses
   
34,101
     
0
     
34,101
     
95,931
     
0
     
95,931
 
                                                 
Net loss from Operations before Other Expense:
   
(34,101
)
   
0
     
(34,101
)
   
(95,931
)
   
0
     
(95,931
)
Loss on conversion of debt
   
0
     
(154,000
)
   
(154,000
)
   
0
     
(154,000
)
   
(154,000
)
Foreign exchange gain
   
0
     
0
     
0
     
0
     
0
     
0
 
Interest on debt
   
(3,457
)
   
0
     
(3,457
)
   
(6,914
)
   
0
     
(6,914
)
                                                 
Net loss before income tax
   
(37,558
)
   
(154,000
)
   
(191,558
)
   
(102,845
)
   
(154,000
)
   
(256,845
)
Provision for income tax
   
0
     
 0
     
0
     
0
     
0
     
0
 
                                                 
Net Loss
 
$
(37,558
)
 
$
 (154,000
)
 
$
(191,558
)
 
$
(102,845
)
 
$
(154,000
)
 
$
(256,845
)
                                                 
Basic and diluted loss per share
 
$
(0.67
)
         
$
(3.41
)
 
$
(1.91
)
           
(4.78
)
                                                 
                                                 
Weighted average number of shares outstanding
   
56,133
             
56,133
     
53,774
             
53,774
 

The accompanying condensed notes are an integral part of these financial statements.
 
 
3

 
 
   
For the six months ended January 31, 2013
 
   
As reported
   
Adjustment
   
As restated
 
Cash Flow from Operating Activities
                 
Net loss
 
$
(102,845
)
 
$
(154,000
)
 
$
(256,845
)
Adjustments to reconcile net loss to net cash used:
                       
Services paid with common stock
   
16,800
     
  0
     
16,800
 
Imputed interest
   
6,914
     
            0
     
6,914
 
Loss on conversion of debt
   
0
     
          154,000
     
154,000
 
Changes in:
                       
Prepaid expense
   
0
     
0
     
0
 
Accounts payable
   
10,216
     
0
     
10,216
 
Management fees payable
   
20,500
     
0
     
153,004
 
Accrued interest and fees
   
0
     
(0
)
   
0
 
Net cash used in operating activities
   
(48,415
   
(0
)
   
(48,415
)
                         
                         
Cash Flow from Investing Activities
                       
Net cash used in investing activities
 
$
0
   
$
0
   
$
0
 
                         
                         
Cash Flow from Financing Activities
                       
                         
Proceeds from shareholder loan
   
0
     
0
     
0
 
Loans payable
   
0
     
0
     
0
 
Convertible loan subscription
   
0
     
0
     
0
 
Proceeds from shares issued for cash
   
50,000
     
0
     
50,000
 
Proceeds from shares issued to founders
   
0
     
0
     
0
 
                         
Net cash provided by financing activities
 
$
50,000
   
$
0
   
$
50,000
 
                         
Change in cash for the period
   
1,585
     
0
     
1,585
 
Cash at beginning of period
   
0
     
0
     
0
 
Cash at end of period
 
$
1,585
   
$
0
   
$
1,585
 
                         
Cash Paid For:
                       
Interest
 
$
0
   
$
0
   
$
0
 
Income Tax
 
$
0
   
$
0
   
$
0
 
Non cash transactions:
                       
Conversions of debt
 
$
50,000
   
$
0
   
$
50,000
 
Cancellation of common shares
 
$
0
   
$
0
   
$
0
 
 
 
4